Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06314386
Other study ID # 23.139.01
Secondary ID R01NR020866
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 6, 2025
Est. completion date February 28, 2029

Study information

Verified date March 2024
Source Boston College
Contact Brittney J van de Water, PhD
Phone 617-552-8718
Email sulligst@bc.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized trial uses the evidence-based Systems Analysis and Improvement Approach (SAIA) adapted for tuberculosis (SAIA-TB) to assess the comprehensive tuberculosis (TB) care cascade across 16 clinics in rural Eastern Cape, South Africa to improve patient outcomes. The aims of this study are to: - Evaluate the effectiveness of SAIA-TB use in clinics on TB cascade outcomes for TB patients and with high-risk contacts - Determine the drivers of SAIA-TB implementation success or failure across clinics The investigators hypothesize that SAIA-TB implementation will lead to a 20% increase in each of: TB screening, TB preventive treatment initiation, and TB disease treatment initiation during the 18-month intervention period.


Description:

This four-wave stepped wedge crossover cluster randomized trial will assess the effectiveness of the SAIA-TB intervention (Aim 1). A total of 16 clinics in four municipalities within the Sarah Baartman-district, Eastern Cape, South Africa will be included. The SAIA-TB intervention will be implemented at the clinic level. Public sector clinic staff and clinic managers, supported by study personnel, will deliver the intervention over an 18-month implementation phase, followed by a 12-month maintenance phase led by clinic managers without additional study personnel support, to provide evidence on intervention impact under ideal circumstances, as well as sustained effect over time. Aim 2 will consist of interviews and using the organization readiness for implementing change (ORIC) with facilities early in SAIA-TB implementation (within 3 months of initiating the intervention) to identify clinic-level attributes that affect intervention adoption. Additionally, the Consolidated Framework for Implementation Research (CFIR) will guide data collection and interpretation related to implementation, assess fidelity to intervention protocol, describe intervention adaptations when integrated into routine management systems, and identify clinic-level determinants of successful SAIA-TB implementation. Recurrent measurement of structural readiness and implementation dose (as a function of quality and quantity) at the clinic level will inform guidance on essential structural needs to implement SAIA-TB. The trial will culminate in a dissemination package, summarizing results and providing implementation guidance to support scale-up.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 19560
Est. completion date February 28, 2029
Est. primary completion date February 29, 2028
Accepts healthy volunteers No
Gender All
Age group 0 Years and older
Eligibility Aim 1: 1. Inclusion Criteria for clinics: - Location in the municipalities of Dr. Beyers Naude, Blue Crane Route, Makana, Ndlambe, Sundays River Valley, Kou-Kamma, or Kouga within the Sarah Baartman district, Eastern Cape, South Africa - Within 2 hours' drive to Gqeberha, where the study office is located - Only one clinic per town/area/location to ensure a mix of rural, semi-rural, semi urban - Clinic capacity/Patient volume > 700 total outpatient attendees per month (8,400 patients per year) - Staff size of at least 5 employees with a mixture of at least 2 professional nurses, 1 or 2 pharmacist/pharmacy technicians, at least 1 data capturer, a social worker, and multiple community health workers who are clinic-based or part of ward-based outreach teams. - Must have an acting Clinic Manager 2. Exclusion Criteria for clinics: - Clinic managers and/or staff are unwilling to participate Aim 2: 1. Inclusion Criteria: - 18 years and older - Frontline clinical and/or managerial staff, district-level TB management - Ability to provide informed consent 2. Exclusion Criteria: - Under age 18 - Unwilling to provide informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Systems Analysis and Improvement Approach for TB (SAIA-TB)
The Systems Analysis and Improvement Approach for TB (SAIA-TB) is a five-step systems analysis and iterative improvement cycle intervention which will be implemented by clinic staff with support from study personnel in intervention clinics. Components of the intervention include TB cascade analysis, patient flow mapping and continuous quality improvement, aimed to incrementally optimize TB screening, evaluation, diagnosis, TB preventive therapy and TB disease treatment initiation, successful treatment, and TB-free survival among the population at the intervention clinics.

Locations

Country Name City State
South Africa Addo Clinic Addo
South Africa Lukhanyiso Clinic Addo
South Africa Kwa-Nonqubela Clinic Alexandria
South Africa Marselle Clinic Boesmansriviermond
South Africa Masakhane Clinic Hankey
South Africa Humansdorp Clinic Humansdorp
South Africa Pellsrus Clinic Jeffrey's Bay
South Africa Joubertina CHC Joubertina
South Africa Louterwater Clinic Joubertina
South Africa Twee Riviere Clinic Joubertina
South Africa Kareedouw Clinic Kareedouw
South Africa Kenton On Sea Clinic Kenton on Sea
South Africa Kirkwood Clinic Kirkwood
South Africa Moses Mabida Clinic Kirkwood
South Africa Imizamo Yetho Clinic Patensie
South Africa Nkwenkwezi Clinic Port Alfred

Sponsors (6)

Lead Sponsor Collaborator
Boston College Boston University, Medical Research Council, South Africa, National Institute of Nursing Research (NINR), National Institutes of Health (NIH), University of Washington

Country where clinical trial is conducted

South Africa, 

Outcome

Type Measure Description Time frame Safety issue
Primary TB Screening The proportion of individuals screened with WHO TB symptom screen in the target population 18 months
Primary Linkage to care for TB disease treatment The proportion of individuals initiating TB disease treatment among those with a positive diagnostic evaluation 18 months
Primary TB Evaluation The proportion of individuals receiving a diagnostic evaluation among those with a positive screening 18 months
Primary TB Diagnosis The proportion of individuals diagnosed with TB among those who completed a diagnostic evaluation 18 months
Secondary Successful TB Prevention Treatment (TPT) Outcome The proportion of individuals who complete TB Prevention Treatment (TPT) among those who initiate TPT 18 months
Secondary Successful TB Outcome The proportion of individuals cured or completing treatment for TB disease among those who initiate TB treatment 18 months
See also
  Status Clinical Trial Phase
Recruiting NCT05738681 - Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial Phase 2/Phase 3
Recruiting NCT05526885 - Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa N/A
Completed NCT04369326 - Community Initiated Preventive Therapy for TB N/A
Recruiting NCT04568967 - TB-CAPT EXULTANT - HIV N/A
Completed NCT02337270 - Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol Phase 1
Not yet recruiting NCT06253715 - Shortened Regimen for Drug-susceptible TB in Children Phase 3
Recruiting NCT04271397 - Immunological Biomarkers in Tuberculosis Management N/A
Withdrawn NCT03639038 - Tuberculosis Diagnosis by Flow Cytometry
Completed NCT03199313 - Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid Phase 1
Recruiting NCT04975178 - Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa Phase 3
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03973970 - Assessing the Ability of the T-SPOT®.TB Test (IQ)
Recruiting NCT04230395 - Alcohol Reduction Among People With TB and HIV in India N/A
Completed NCT04874948 - Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment Phase 1
Active, not recruiting NCT02906007 - Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV Phase 1/Phase 2
Not yet recruiting NCT05917210 - Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda N/A
Not yet recruiting NCT06017843 - Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding N/A
Not yet recruiting NCT05845112 - Start Taking Action For TB Diagnosis
Active, not recruiting NCT02715271 - Study of TB Lesions Obtained in Therapeutical Surgery
Completed NCT02781909 - Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis Phase 2